Organic and Sustainable Cannabis

Organic and Sustainable Cannabis

Close
Please fill out the form below and we will get back to you as soon as we can.






    Partnerships

    Our Partners

    We partner with MCG Pharma and Rajamangala University of Technology



    MCG Pharma

    MGC Pharmaceuticals Limited (‘MGC’) (ASX: MXC) is a biopharma company with a “Nature to Medicine” strategy at the forefront of the emerging phytocannabinoid and plant derived medicine markets. The company’s mission is to build an innovative, global bio-pharma company providing standardised, affordable plant derived medicines of the highest regulatory compliance for targeted global markets.


    MGC Pharma implementing a “Nature to Medicine” core strategy. MGC currently holds pipelines for phytocannabinoid-based medications and unique formulations (Phytomedicines), both proprietary and for third parties, all under GMP certified regulations and facilities. This includes the ability to create API (Active Pharmaceutical Ingredient) of various phytocannabinoids alongside compounding to be used in the pharmaceutical treatment and research globally. MGC has developed an efficient production pipeline of phytocannabinoid derived medications, with multiple products currently being prescribed to patients, and products currently in clinical development and testing.


    Visit Website


    Rajamangala University of Technology

    Lanna Herbal Medicines has entered into an exclusive research agreement with Rajamangala University of Technology in Chiang Mai, one of Thailand’s most forward thinking universities. We have co-funded the construction of a state of the art research facility, and the development of Thailand’s first undergraduate program in Cannabis Science and Technology.


    The collaboration has several purposes: to study and improve hemp species to find new cannabinoid strains with medicinal properties; to study and improve methods of hemp cultivation to increase product quantity and quality; to study and develop new hemp species for Thailand; to study and improve cannabidiol (CBD) as a mixture in Thai herbal products including but not limited to turmeric, lemongrass, black galingale, gotu kola and chrysanthemum; to study and improve herbs for industrial processing and export to the global market; to study and develop food and beverage, nutrition, wellness, skincare, cosmetic products and perfume that contain CBD; and to utilise the Bio-Circular-Green (BCG) economy model to study and improve hemp and Thai traditional herbs.


    Visit Website